Randox Acusera Maternal Screening Control



Product Image
Request Pricing


Turn On Instant Requests

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The Randox Acusera Maternal Screening control is the only commercially available control to cover all six analytes used during first and second trimester screening of Down’s Syndrome and Spina Bifida.

Assayed instrument specific target values and ranges are provided for AFP, β hCG, Inhibin A, PAPP-A, Total hCG and Unconjugated Estriol. The inclusion of Inhibin A and PAPP-A eliminates the need to purchase additional controls at extra expense.

Maternal Screening Control Features:
  • Lyophilised for enhanced stability
  • 100% human serum
  • Third party control
  • Unconjugated oestriol present at clinically significant levels
  • Reconstituted stability of 7 days at +2-8oC


Analytes:
AFP β hCG Inhibin A PAPP-A Total hCG Unconjugated Estriol

Product Overview

Product Image

Randox Acusera Maternal Screening Control

Manufacturer Randox Laboratories Ltd.

Be the first to review this product